The potential therapeutic role of selenium in diffuse large B-cell lymphoma
The clinical background to this work confirms the very poor outcome of patients with recurrent diffuse large B-cell lymphoma (DLBCL) and highlights the need for better therapies. One such potential option would be to add selenium (Se) to conventional chemotherapy. Previous work has demonstrated the...
| Main Author: | |
|---|---|
| Published: |
Queen Mary, University of London
2011
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.531575 |